Abstract
Breast and ovarian cancer susceptibility gene 1 (BRCA1) was identified from the genomic analysis of breast cancer families. Women heterozygous for a germ line mutation in the BRCA1 gene have a high risk of developing breast or ovarian cancers. BRCA1-mutant mice were created to study the function of BRCA1, but the heterozygous mice were healthy. The reason for this difference in phenotype between mice and humans is unknown. Here, I emphasize that the estrous cycle of mice differs from the menstrual cycle of humans and that this difference may be responsible for the lack of tumorigenesis in the BRCA1-mutant mouse model. Even if this difference in the cycles is not responsible for the phenotype difference, researchers should note this estrous cycle variation in reports of mouse BRCA1 studies. A method for reducing the influence of the short estrous cycle in mouse studies is also discussed in this text.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.